Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Aptamer therapeutics advance.

Jennifer F Lee1, Gwendolyn M Stovall, Andrew D Ellington

  • 1University of Texas at Austin, 1 University Station, A4800, Austin, TX 78712, USA.

Current Opinion in Chemical Biology
|April 20, 2006
PubMed
Summary

Aptamers, or nucleic acid-based drugs, offer advantages over antibodies for therapeutic development. Chemical synthesis and improved properties are accelerating their use in clinical trials and drug applications.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Agnostic material classification using differential de Bruijn graphs of DNA imprints.

bioRxiv : the preprint server for biology·2026
Same author

The Origin of Life in the Light of Evolution.

ArXiv·2026
Same author

Overestimating zero-shot fitness prediction: Broad benchmarks mask local failures and practical limitations.

bioRxiv : the preprint server for biology·2026
Same author

Integrating Transcription Factors with Electrochemical Pendulum Bioanalysis for Hormone Detection.

Journal of the American Chemical Society·2026
Same author

Fieldable isothermal nucleic acid test for rapid semi-quantitative visual readout of enterococci in recreational waters.

PeerJ·2026
Same author

Widespread omission of aptamer-target binding verification in aptasensor development: Consequences for sensor performance and the need for a K<sub>d</sub> gate.

Biosensors & bioelectronics·2026

Area of Science:

  • Biochemistry
  • Molecular Biology
  • Drug Development

Background:

  • Aptamers are nucleic acid molecules selected for high affinity and specificity to protein targets.
  • They offer advantages over monoclonal antibodies, including chemical synthesis and tunable pharmacokinetic properties.
  • Aptamers are emerging as a promising class of therapeutics with demonstrated efficacy in preclinical models.

Purpose of the Study:

  • To highlight the advantages of aptamers in therapeutic development.
  • To discuss the current status and future potential of aptamers in clinical applications.
  • To emphasize the impact of recent advances in aptamer selection and delivery technologies.

Main Methods:

  • Selection technologies for identifying aptamers against therapeutic targets.
  • Chemical synthesis and modification strategies for enhancing aptamer stability and pharmacokinetics.
  • Preclinical and clinical evaluation of aptamer-based therapeutics.

Main Results:

  • Aptamers demonstrate target affinities and specificities comparable to monoclonal antibodies.
  • Chemical synthesis allows for modifications that improve aptamer stability and drug-like properties.
  • Several aptamers have shown efficacy in cell and animal models, with some progressing to clinical trials or market.

Conclusions:

  • Aptamers represent a powerful alternative to antibody-based therapeutics.
  • Advancements in selection and delivery technologies are poised to accelerate aptamer drug development.
  • The therapeutic potential of aptamers is increasingly being realized in clinical settings.

Related Experiment Videos